Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss, a device for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; and ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles. The company is headquartered in Toronto, Canada.
Over the last 12 months, insiders at Venus Concept Inc. have bought $0 and sold $190,521 worth of Venus Concept Inc. stock.
On average, over the past 5 years, insiders at Venus Concept Inc. have bought $4.96M and sold $511,350 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 60,000 shares for transaction amount of $13,200 was made by PORTARO ROSS (President Global Sales) on 2022‑11‑21.
2024-06-11 | Sale | Masters Michael Willingham | 10 percent owner | 102,717 1.757% | $1.20 | $122,829 | -21.72% | |
2024-06-07 | Sale | Masters Michael Willingham | 10 percent owner | 55,382 1.1453% | $1.22 | $67,692 | -6.13% | |
2022-11-29 | Sale | Natale Anthony | director | 51,431 0.0049% | $0.24 | $12,503 | -34.44% | |
2022-11-28 | Sale | Natale Anthony | director | 51,428 0.0052% | $0.27 | $13,680 | -36.39% | |
2022-11-25 | Sale | Natale Anthony | director | 51,428 0.0051% | $0.31 | $15,752 | -44.94% | |
2022-11-23 | Sale | Natale Anthony | director | 51,428 0.0046% | $0.33 | $16,971 | -53.33% | |
2022-11-22 | Sale | Natale Anthony | director | 51,428 0.0044% | $0.20 | $10,106 | -25.27% | |
2022-11-21 | PORTARO ROSS | President Global Sales | 60,000 0.0062% | $0.22 | $13,200 | -16.67% | ||
2022-11-18 | DE SILVA RAJIV | Officer | 1.25M 0.1312% | $0.20 | $250,000 | -5.56% | ||
2022-11-18 | HOLLMIG STANLEY TYLER | director | 250,000 0.0262% | $0.20 | $50,000 | -5.56% | ||
2022-11-18 | Varghese Hemanth Jacob | President/Chief Bus. Officer | 250,000 0.0262% | $0.20 | $50,000 | -5.56% | ||
2022-09-16 | Della Penna Domenic | Chief Financial Officer | 60,000 0.0059% | $0.59 | $35,403 | -65.70% | ||
2022-09-12 | Georgiadis Anna | VP, Global HR | 12,782 0.0013% | $0.71 | $9,083 | -69.23% | ||
2022-08-30 | Serafino Domenic | Chief Executive Officer | 37,500 0.0039% | $0.33 | $12,304 | -31.25% | ||
2022-05-24 | HOLLMIG STANLEY TYLER | 40,000 0.004% | $0.64 | $25,720 | -53.31% | |||
2022-05-20 | Serafino Domenic | Chief Executive Officer | 65,000 0.007% | $0.75 | $48,750 | -57.30% | ||
2022-05-17 | PORTARO ROSS | President Global Sales | 10,000 0.0011% | $0.85 | $8,500 | -60.46% | ||
2022-03-25 | Serafino Domenic | Chief Executive Officer | 50,000 – | $0 | $0 | -72.50% | ||
2021-12-16 | PORTARO ROSS | President Global Sales | 20,000 0.0025% | $1.35 | $27,000 | -53.25% | ||
2021-12-15 | EW Healthcare Partners, L.P. | 10 percent owner | 3.92M 0.4649% | $1.25 | $4.9M | -50.47% |
Masters Michael Willingham | 10 percent owner | 383345 6.032% | $0.82 | 0 | 2 | |
BARRY RICHARD SCOTT | 16337856 295.4858% | $0.82 | 2 | 0 | <0.0001% | |
EW Healthcare Partners, L.P. | 10 percent owner | 16337856 295.4858% | $0.82 | 2 | 0 | <0.0001% |
Kong Garheng | 6795621 122.9053% | $0.82 | 2 | 0 | <0.0001% | |
HealthQuest Partners II, L.P. | 10 percent owner | 6795621 122.9053% | $0.82 | 2 | 0 | <0.0001% |
Kliman Gilbert H | 5355786 96.8645% | $0.82 | 1 | 0 | ||
InterWest Partners IX, LP | 10 percent owner | 5355786 96.8645% | $0.82 | 1 | 0 | |
DE SILVA RAJIV | Officer | 1250000 22.6075% | $0.82 | 1 | 0 | <0.0001% |
Serafino Domenic | Chief Executive Officer | 1008758 18.2444% | $0.82 | 7 | 0 | <0.0001% |
MOLL FREDERIC H | director | 929809 16.8165% | $0.82 | 1 | 0 | |
SEDCO Capital Cayman Ltd | 10 percent owner | 922456 16.6835% | $0.82 | 0 | 6 | |
Natale Anthony | director | 641507 11.6023% | $0.82 | 0 | 5 | |
HOLLMIG STANLEY TYLER | director | 290000 5.2449% | $0.82 | 2 | 0 | <0.0001% |
Varghese Hemanth Jacob | President/Chief Bus. Officer | 250000 4.5215% | $0.82 | 1 | 0 | <0.0001% |
Della Penna Domenic | Chief Financial Officer | 126663 2.2908% | $0.82 | 2 | 0 | <0.0001% |
PORTARO ROSS | President Global Sales | 120000 2.1703% | $0.82 | 4 | 0 | <0.0001% |
Zaring Chad A | CCO | 80000 1.4469% | $0.82 | 3 | 0 | <0.0001% |
Sullivan Keith J | director | 80000 1.4469% | $0.82 | 1 | 4 | <0.0001% |
Rhodes Ryan | President and CEO | 66666 1.2057% | $0.82 | 1 | 0 | |
Zingaretti Gabriele | Chief Operations Officer | 15212 0.2751% | $0.82 | 1 | 0 | |
Georgiadis Anna | VP, Global HR | 12782 0.2312% | $0.82 | 1 | 0 | <0.0001% |
Iger Yoni | VP, RA/QA/Clinical Affairs | 5181 0.0937% | $0.82 | 1 | 0 | <0.0001% |
Lee Ray F | See Remarks | 700 0.0127% | $0.82 | 1 | 0 |
No records found… |